Enabling rapid and high quality targeted sequencing and moving precision medicine forward

At Paragon Genomics, we develop and commercialize rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets. Our proprietary CleanPlex™ background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, simple, and cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.

Who We Are

At Paragon Genomics, we are a passionate and dedicated team of people whose goal is to provide cutting-edge technologies and solutions to the global genomic research and application community and move precision medicine forward. The team is composed of industry veterans and academic experts who previously worked with well-known industry leading companies and institutions such as Affymetrix, Novartis, Applied Biosystems, Siemens Healthcare, Stanford and Harvard.

Paragon Genomics team also proudly graduated from the California Life Sciences Institute’s (CLSI) Spring 2016 FAST Advisory Program! buff.ly/2bPKIIN. We are also honored to be accepted into the renowned StartX Fall 2016 Accelerator Program. http://startx.com/accelerator.